Show Notes 179: From Dark Matter to Digital Twins: How Concr is Revolutionising Cancer Treatment Prediction
Irina Barbina (CEO) and Matthew Griffiths (CTO) explain how Concr is using predictive modelling and digital twins to transform cancer drug development.